Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

氢氧化铝片 - NMPA Drug Approval Details

Approvals/NMPA/Aluminium Hydroxide Tablets

Approved

化学药品

Aluminium Hydroxide Tablets

河北利鑫制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 20, 2020
Approval ID: 7Leaf7e1TOf
Company: 河北利鑫制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7Leaf7e1TOf
Approval Number: 国药准字H13020723
Generic Name: 氢氧化铝片
Generic Name En: Aluminium Hydroxide Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.3g
Reg Date: 2020-09-20
Company Name: 河北利鑫制药有限公司
Company Address: 石家庄市鹿泉区黄壁庄镇
Company Detail Path: /organization/he-bei-li-xin-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 20, 2020

Approval ID

7Leaf7e1TOf

Type

化学药品

Back to NMPA Approvals